Fig. 3From: In-silico activity prediction and docking studies of some flavonol derivatives as anti-prostate cancer agents based on Monte Carlo optimizationSuperposition of the abiraterone output docked ligand (blue) and the co-crystallized ligand (green) of 3RUKABack to article page